Insider Trading activities of Biosante Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biosante Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biosante Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Biosante Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is ANIP. The reporting company's CIK number is 1023024.
The total value of stock buying since 2005 is $1,780,168.
The total value of stock sales since 2005 is $46,862,670.
The total value of stock option exercises since 2005 is $2,240,202.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Biosante Pharmaceuticals Inc (ANIP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2016-11 0 $0 0 $0 5,458 $107,413
2016-08 0 $0 49,955 $3,346,573 53,178 $810,432
2016-01 0 $0 0 $0 16,446 $104,596
2015-12 0 $0 3,500 $151,410 0 $0
2015-11 2,500 $102,375 0 $0 0 $0
2015-09 0 $0 0 $0 21,166 $444,598
2015-08 0 $0 0 $0 10,000 $63,600
2015-07 0 $0 0 $0 7,395 $47,032
2015-06 0 $0 0 $0 9,062 $59,809
2015-05 0 $0 0 $0 20,520 $251,253
2015-03 0 $0 545,000 $34,387,500 0 $0
2014-09 4,000 $108,976 0 $0 0 $0
2014-06 0 $0 5,000 $171,400 0 $0
2014-05 2,000 $60,760 1,381 $41,454 0 $0
2014-03 0 $0 249,768 $8,268,608 0 $0
2013-11 9,000 $101,430 0 $0 0 $0
2013-08 10,000 $74,660 0 $0 0 $0
2011-11 3,000 $7,110 0 $0 0 $0
2011-08 117,000 $267,920 0 $0 0 $0
2011-01 17,000 $29,810 0 $0 0 $0
2010-12 20,000 $29,400 0 $0 0 $0
2009-01 10,000 $10,900 0 $0 0 $0
2008-12 28,000 $32,675 0 $0 0 $0
2008-05 15,000 $53,820 0 $0 0 $0
2008-01 65,000 $240,941 0 $0 0 $0
2007-12 88,000 $332,465 0 $0 0 $0
2007-05 0 $0 7,500 $50,881 0 $0
2006-12 15,000 $40,365 0 $0 0 $0
2006-11 100,000 $150,000 0 $0 0 $0
2006-09 50,000 $80,000 0 $0 0 $0
2006-07 29,600 $56,561 0 $0 0 $0
2006-03 0 $0 0 $0 152,813 $351,469
2005-04 0 $0 115,277 $444,844 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Biosante Pharmaceuticals Inc insiders (ANIP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2016-11-15 Brown Robert E. Jr Option Ex 5,458 19.68 107,413
2016-08-22 Przybyl Arthur (President and CEO) Sale 37,455 66.97 2,508,361
2016-08-22 Przybyl Arthur (President and CEO) Option Ex 53,178 15.24 810,432
2016-08-08 Schrepfer Robert W (VP Bus Dev & Con Mfg) Sale 12,500 67.06 838,212
2016-01-08 Przybyl Arthur (President and CEO) Option Ex 16,446 6.36 104,596
2015-12-18 Marken James G. (Vice President, Operations) Sale 3,500 43.26 151,410
2015-11-12 Przybyl Arthur (President and CEO) Buy 2,500 40.95 102,375
2015-09-25 Arnold Charlotte C. (Vice President and CFO) Option Ex 19,060 19.68 375,100
2015-09-02 Arnold Charlotte C. (Vice President and CFO) Option Ex 2,106 33.00 69,498
2015-08-10 Przybyl Arthur (President and CEO) Option Ex 10,000 6.36 63,600
2015-07-17 Marken James G. (Vice President, Operations) Option Ex 7,395 6.36 47,032
2015-06-18 Schrepfer Robert W (VP Bus Dev & Con Mfg) Option Ex 9,062 6.60 59,809
2015-05-13 Marken James G. (Vice President, Operations) Option Ex 9,020 19.68 177,513
2015-05-07 Przybyl Arthur (President and CEO) Option Ex 5,000 6.36 31,800
2015-05-06 Arnold Charlotte C. (VP and CFO) Option Ex 4,000 6.36 25,440
2015-05-06 Schrepfer Robert W (VP Bus Dev & Con Mfg) Option Ex 2,500 6.60 16,500
2015-03-19 Marken James G. (Vice President, Operations) Sale 15,000 66.50 997,500
2015-03-12 Marshbanks Tracy (Director) Sale 210,000 63.00 13,230,000
2015-03-12 Arnold Charlotte C. (Vice President and CFO) Sale 45,000 63.00 2,835,000
2015-03-12 Przybyl Arthur (President and CEO) Sale 75,000 63.00 4,725,000
2015-03-12 Raynor Daniel Sale 200,000 63.00 12,600,000
2014-09-15 Mangano Ross J Buy 3,000 27.49 82,476
2014-09-09 Przybyl Arthur (President and CEO) Buy 1,000 26.50 26,500
2014-06-18 Marken James G. (Vice President, Operations) Sale 5,000 34.28 171,400
2014-05-08 Marshbanks Tracy (Director) Sale 1,381 30.02 41,454
2014-05-07 Mangano Ross J Buy 2,000 30.38 60,760
2014-03-21 Marshbanks Tracy (Director) Sale 5,617 31.06 174,469
2014-03-20 Brown Robert E. Jr Sale 10,000 31.76 317,600
2014-03-20 Marshbanks Tracy (Director) Sale 16,150 31.54 509,387
2014-03-19 Brown Robert E. Jr Sale 10,922 32.87 359,006
2014-03-19 Marshbanks Tracy (Director) Sale 4,246 32.98 140,024
2014-03-18 Brown Robert E. Jr Sale 20,542 33.83 694,935
2014-03-18 Marshbanks Tracy (Director) Sale 21,112 33.83 714,134
2014-03-17 Brown Robert E. Jr Sale 10,339 34.75 359,280
2014-03-14 Brown Robert E. Jr Sale 29,659 34.28 1,016,858
2014-03-14 Raynor Daniel Sale 12,347 33.85 417,945
2014-03-13 Brown Robert E. Jr (Chairman) Sale 52,404 31.69 1,660,682
2014-03-12 Brown Robert E. Jr (Chairman) Sale 35,319 33.66 1,188,837
2014-03-12 Raynor Daniel Sale 21,111 33.89 715,451
2013-11-07 Mangano Ross J Buy 9,000 11.27 101,430
2013-08-20 Mangano Ross J Buy 10,000 7.47 74,660
2011-11-14 Rosenow Edward C Iii (Director) Buy 3,000 2.37 7,110
2011-08-15 Sullivan Louis W (Director) Buy 10,000 2.67 26,700
2011-08-12 Mangano Ross J (Director) Buy 25,000 2.40 60,000
2011-08-08 Donenberg Philip B (Sr. VP of Finance, CFO & Secy) Buy 1,000 2.23 2,230
2011-08-05 Donenberg Philip B (Sr. VP of Finance, CFO & Secy) Buy 1,000 2.19 2,190
2011-08-05 Mangano Ross J (Director) Buy 80,000 2.21 176,800
2011-01-21 Donenberg Philip B (Sr. VP of Finance, CFO & Sec'y) Buy 1,000 1.88 1,880
2011-01-19 Donenberg Philip B (Sr. VP of Finance, CFO & Sec'y) Buy 1,000 1.88 1,880
2011-01-18 Simes Stephen M (Vice Chairman, President & CEO) Buy 5,000 1.77 8,850
2011-01-13 Sullivan Louis W (Director) Buy 10,000 1.72 17,200
2010-12-07 Mangano Ross J (Director) Buy 20,000 1.47 29,400
2009-01-02 Simes Stephen M (Vice Chairman, President & CEO) Buy 10,000 1.09 10,900
2008-12-31 Donenberg Philip B (CFO, Treasurer and Secretary) Buy 3,000 1.00 3,000
2008-12-29 Mangano Ross J (Director) Buy 25,000 1.19 29,675
2008-05-12 Mangano Ross J (Director) Buy 15,000 3.59 53,820
2008-01-08 Kjaer Peter (Director) Buy 7,700 3.67 28,220
2008-01-07 Kjaer Peter (Director) Buy 7,300 3.59 26,221
2008-01-04 Mangano Ross J (Director) Buy 50,000 3.73 186,500
2007-12-20 Mangano Ross J (Director) Buy 25,000 3.98 99,500
2007-12-19 Mangano Ross J (Director) Buy 50,000 3.69 184,700
2007-12-14 Donenberg Philip B (CFO, Treasurer and Secretary) Buy 2,000 3.75 7,510
2007-12-14 Simes Stephen M (Vice Chair, President & CEO) Buy 10,000 3.70 37,000
2007-05-07 Holubow Fred (Director) Sale 2,000 6.92 13,850
2007-05-04 Holubow Fred (Director) Sale 5,500 6.73 37,031
2006-12-26 Mangano Ross J (Director) Buy 15,000 2.69 40,365
2006-11-16 Mangano Ross J (Director) Buy 100,000 1.50 150,000
2006-09-28 Morgenstern Victor A (Director) Buy 50,000 1.60 80,000
2006-07-20 Donenberg Philip B (CFO, Treasurer and Secretary) Buy 1,000 1.95 1,945
2006-07-19 Mangano Ross J (Director) Buy 14,800 1.90 28,120
2006-07-14 Mangano Ross J (Director) Buy 13,800 1.92 26,496
2006-03-27 Donenberg Philip B (CFO, Treasurer and Secretary) Option Ex 52,188 2.30 120,032
2006-03-27 Simes Stephen M (Vice Chairman, President & CEO) Option Ex 100,625 2.30 231,437
2005-04-21 Bell Steven J (Pre-Clinical Dev) Sale 4,100 4.01 16,514
2005-04-19 Lehman Leah M (Vice President, Prod) Sale 80,377 3.78 304,146
2005-04-14 Lehman Leah M (Vice President, Prod) Sale 29,400 4.04 118,629

Insider trading activities including stock purchases, stock sales, and option exercises of ANIP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biosante Pharmaceuticals Inc (symbol ANIP, CIK number 1023024) see the Securities and Exchange Commission (SEC) website.